Page last updated: 2024-09-02

alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid

alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol has been researched along with 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid in 1 studies

Compound Research Comparison

Studies
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)
Trials
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)
Recent Studies (post-2010)
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)
Studies
(3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid)
Trials
(3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid)
Recent Studies (post-2010) (3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid)
9012755265

Protein Interaction Comparison

ProteinTaxonomyalpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol (IC50)3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (IC50)
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)0.1139
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)0.1139
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)0.1139
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)0.1139
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)0.1139
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)0.1139
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)0.1139

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cler, JA; Iyengar, S; Mick, SJ; Rao, TS; Wood, PL1

Other Studies

1 other study(ies) available for alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid

ArticleYear
Inhibition of climbing and mossy fiber, and basket and stellate cell inputs to mouse cerebellar Purkinje cells by novel anti-ischemic agents, ifenprodil and BMY-14802.
    Life sciences, 1990, Volume: 47, Issue:1

    Topics: Analysis of Variance; Animals; Cyclic GMP; Harmaline; Male; Methamphetamine; Mice; Mice, Inbred Strains; Neurons; Pentylenetetrazole; Piperazines; Piperidines; Purkinje Cells; Pyrimidines; Radioimmunoassay; Receptors, Amino Acid; Receptors, Cell Surface

1990